PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹570 Cr | ₹547 Cr | ₹657 Cr | ₹853 Cr | ₹774 Cr |
What is the latest Total Current Liabilities ratio of PFIZER ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹570 Cr |
| Mar2024 | ₹547 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹853 Cr |
| Mar2021 | ₹774 Cr |
How is Total Current Liabilities of PFIZER Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹570 Cr | 4.20 | |
| Mar2024 | ₹547 Cr | -16.85 | |
| Mar2023 | ₹657 Cr | -22.93 | |
| Mar2022 | ₹853 Cr | 10.14 | |
| Mar2021 | ₹774 Cr | - | |
Compare Total Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,707.1 Cr | 0.2% | -4.6% | -20.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.2% |
-4.6% |
-20.7% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses